SCHEMBL16401698

SCHEMBL16401698

[c]1cc2c(OCc3ccccc3)cccc2o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.53
MAPK1 P28482 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAOB P27338 1/20 0.47
HTR1A P08908 2/20 0.46
DRD2 P14416 2/20 0.46
EDNRA P25101 1/20 0.44
SRD5A2 P31213 1/20 0.42
LIPE Q05469 1/20 0.41
LTA4H P09960 1/20 0.41
MAPK14 Q16539 1/20 0.41
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
ABCB1 P08183 2/20 0.40
GAA P10253 1/20 0.40
PLAU P00749 1/20 0.40
PLAT P00750 1/20 0.40
F9 P00740 1/20 0.40
F10 P00742 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5537428 0.79 CYP2A6 (0.51) MAPTTDP1L3MBTL1HTR1ADRD2
SCHEMBL28434999 0.77 ABCB1 (0.47) MAOBHTR1ADRD2ABCB1
SCHEMBL15349794 0.76 F2RL3 (0.46) MAPTL3MBTL1MAOBHTR1ADRD2
SCHEMBL3372411 0.74 MAOB (0.64) MAPTMAPK1TDP1L3MBTL1MAOB
SCHEMBL3380112 0.73 CYP2A6 (0.47) MAPTMAPK1EDNRABCHEACHE
SCHEMBL339812 0.71 MAPT (0.71) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL18678480 0.71 L3MBTL1 (0.56) MAPTMAPK1TDP1L3MBTL1MAOB
SCHEMBL15349539 0.71 MAPT (0.47) MAPTMAPK1TDP1L3MBTL1MAOB
SCHEMBL29568609 0.71 MRGPRX4 (0.67) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL27629 0.71 MRGPRX4 (0.67) MAPTMAPK1TDP1L3MBTL1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022206-B1 EPHA4 INHIBITORS AS NEUROPROTECTIVE AGENTS UNIV HONG KONG SCIENCE & TECH (HK) 2023-07-12 EP disclosed
US-9629830-B2 EphA4 inhibitors as neuroprotective agents THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-04-25 US disclosed
US-20160152618-A1 EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2016-06-02 US disclosed
EP-3022206-A1 EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS The Hong Kong University of Science and Technology (CN) 2016-05-25 EP disclosed
WO-2015007222-A1 EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152618-A1 EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS EPHA4, EPHA1, EPHA7 MAPT 180/4885MAPK1 145/4885TDP1 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.